Literature DB >> 24706309

Multidisciplinary approach to uncommon, widely metastatic breast cancer.

T-T Sio1, G-R Joliat, N Jrebi.   

Abstract

Worldwide, breast cancer represents the most common malignancy in women. Most diagnoses can be made relatively early. However, aggressive metastatic disease is still possible. We report an unusual case of a neglected 69-year-old woman with an intensely malodorous right breast, back pain, and shooting pain in both of her legs. After obtaining history, clinical examination, magnetic resonance imaging and CT scan, she was found to have widely metastatic breast cancer (ER/PR positive, HER-2 negative, 43% Ki-67), with metastases in vertebral bodies of T1/T4, pleura, lungs, liver, mediastinal and axillary lymph nodes, compression pathological fractures of T12/L3, and an expansive, destructive sacral metastasis. She underwent a thoracolumbar surgical fixation for her lower spine and radiotherapy for the T1 metastasis. She received aromatase inhibitor therapy followed by palliative mastectomy. Here, we reviewed the diagnostic steps, management, multidisciplinary approach and the relevant literature of this rare presentation of a destructive, multi-metastatic breast cancer.

Entities:  

Mesh:

Year:  2014        PMID: 24706309

Source DB:  PubMed          Journal:  Eur Rev Med Pharmacol Sci        ISSN: 1128-3602            Impact factor:   3.507


  3 in total

1.  Circ_0008500 Knockdown Improves Radiosensitivity and Inhibits Tumorigenesis in Breast Cancer Through the miR-758-3p/PFN2 Axis.

Authors:  Deyou Kong; Dongxing Shen; Zhikun Liu; Jun Zhang; Jian Zhang; Cuizhi Geng
Journal:  J Mammary Gland Biol Neoplasia       Date:  2022-03-03       Impact factor: 2.673

2.  mir-129-5p Attenuates Irradiation-Induced Autophagy and Decreases Radioresistance of Breast Cancer Cells by Targeting HMGB1.

Authors:  Jing Luo; Jie Chen; Li He
Journal:  Med Sci Monit       Date:  2015-12-31

3.  miR-22 suppresses tumorigenesis and improves radiosensitivity of breast cancer cells by targeting Sirt1.

Authors:  Xia Zhang; Yuehua Li; Dan Wang; Xiaoer Wei
Journal:  Biol Res       Date:  2017-09-07       Impact factor: 5.612

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.